PMC:7105881 / 40080-40670
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1216 | 479-484 | Gene | denotes | IgG2a | Gene:668478 |
1217 | 244-252 | Species | denotes | SARS-CoV | Tax:694009 |
1218 | 383-391 | Species | denotes | SARS-CoV | Tax:694009 |
1219 | 428-432 | Chemical | denotes | Alum | MESH:C041524 |
1220 | 438-451 | Chemical | denotes | CpG adjuvants | |
1221 | 551-555 | Chemical | denotes | Alum | MESH:C041524 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T241 | 262-270 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T242 | 485-493 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T227 | 60-64 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T228 | 244-252 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T229 | 383-391 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T520 | 152-154 | http://purl.obolibrary.org/obo/CLO_0001022 | denotes | Li |
T521 | 152-154 | http://purl.obolibrary.org/obo/CLO_0007314 | denotes | Li |
T522 | 259-261 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
T523 | 353-355 | http://purl.obolibrary.org/obo/CLO_0001022 | denotes | Li |
T524 | 353-355 | http://purl.obolibrary.org/obo/CLO_0007314 | denotes | Li |
T525 | 381-382 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T526 | 461-462 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T527 | 498-514 | http://purl.obolibrary.org/obo/PR_000000017 | denotes | interferon gamma |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T252 | 114-123 | Chemical | denotes | adjuvants | http://purl.obolibrary.org/obo/CHEBI_60809 |
T253 | 152-154 | Chemical | denotes | Li | http://purl.obolibrary.org/obo/CHEBI_30145 |
T254 | 262-270 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T255 | 353-355 | Chemical | denotes | Li | http://purl.obolibrary.org/obo/CHEBI_30145 |
T256 | 442-451 | Chemical | denotes | adjuvants | http://purl.obolibrary.org/obo/CHEBI_60809 |
T257 | 498-508 | Chemical | denotes | interferon | http://purl.obolibrary.org/obo/CHEBI_52999 |
T258 | 509-514 | Chemical | denotes | gamma | http://purl.obolibrary.org/obo/CHEBI_30212 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T76 | 523-532 | http://purl.obolibrary.org/obo/GO_0046903 | denotes | secretion |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32265848-16919855-36511169 | 146-150 | 16919855 | denotes | 2007 |
32265848-23573979-36511170 | 163-167 | 23573979 | denotes | 2013 |
32265848-23573979-36511171 | 364-368 | 23573979 | denotes | 2013 |
32265848-16919855-36511172 | 584-588 | 16919855 | denotes | 2007 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T229 | 0-169 | Sentence | denotes | Other factors that potentially affect the immunogenicity of SARS subunit vaccines include immunization routes and adjuvants (Zakhartchouk et al., 2007; Li et al., 2013). |
T230 | 170-370 | Sentence | denotes | Significantly high-titer antibodies were induced by monomeric or trimeric SARS-CoV S and S1 proteins through the intramuscular (I.M.) route compared to the subcutaneous (S.C.) route (Li et al., 2013). |
T231 | 371-590 | Sentence | denotes | Moreover, a SARS-CoV RBD subunit vaccine conjugated with Alum plus CpG adjuvants elicited a higher level of IgG2a antibody and interferon gamma (IFN-γ) secretion than the RBD with Alum alone (Zakhartchouk et al., 2007). |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T717 | 42-56 | BV_15 | denotes | immunogenicity |
T718 | 60-64 | SP_10 | denotes | SARS |
T719 | 114-123 | CHEBI:60809;CHEBI:60809 | denotes | adjuvants |
T720 | 195-205 | GO:0042571 | denotes | antibodies |
T721 | 244-252 | SP_10 | denotes | SARS-CoV |
T722 | 383-391 | SP_10 | denotes | SARS-CoV |
T723 | 412-422 | MOP:0000779 | denotes | conjugated |
T724 | 442-451 | CHEBI:60809;CHEBI:60809 | denotes | adjuvants |
T725 | 485-493 | GO:0042571 | denotes | antibody |
T726 | 498-514 | PR:000000017 | denotes | interferon gamma |
T727 | 516-521 | PR:000000017 | denotes | IFN-γ |
T57205 | 42-56 | BV_15 | denotes | immunogenicity |
T14723 | 60-64 | SP_10 | denotes | SARS |
T90462 | 114-123 | CHEBI:60809;CHEBI:60809 | denotes | adjuvants |
T1050 | 195-205 | GO:0042571 | denotes | antibodies |
T33718 | 244-252 | SP_10 | denotes | SARS-CoV |
T51268 | 383-391 | SP_10 | denotes | SARS-CoV |
T8909 | 412-422 | MOP:0000779 | denotes | conjugated |
T83455 | 442-451 | CHEBI:60809;CHEBI:60809 | denotes | adjuvants |
T17832 | 485-493 | GO:0042571 | denotes | antibody |
T54895 | 498-514 | PR:000000017 | denotes | interferon gamma |
T18175 | 516-521 | PR:000000017 | denotes | IFN-γ |